AE Wealth Management LLC cut its position in Humana Inc. (NYSE:HUM – Free Report) by 0.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 19,137 shares of the insurance provider’s stock after selling 78 shares during the period. AE Wealth Management LLC’s holdings in Humana were worth $9,290,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of HUM. Arlington Partners LLC acquired a new position in shares of Humana in the fourth quarter valued at about $29,000. WFA of San Diego LLC acquired a new stake in Humana during the fourth quarter worth about $33,000. U.S. Capital Wealth Advisors LLC purchased a new position in Humana during the fourth quarter valued at approximately $35,000. Householder Group Estate & Retirement Specialist LLC purchased a new position in Humana during the first quarter valued at approximately $39,000. Finally, Delta Asset Management LLC TN purchased a new position in Humana during the fourth quarter valued at approximately $46,000. 93.21% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
HUM has been the subject of several recent research reports. Truist Financial reduced their price target on Humana from $590.00 to $530.00 in a research report on Tuesday, June 20th. JPMorgan Chase & Co. reduced their price target on Humana from $625.00 to $576.00 in a research report on Tuesday, May 30th. Morgan Stanley lifted their price target on Humana from $620.00 to $637.00 and gave the company an “overweight” rating in a research report on Tuesday, April 11th. SVB Securities reduced their price target on Humana from $640.00 to $600.00 in a research report on Thursday, April 27th. Finally, TheStreet upgraded Humana from a “c+” rating to a “b-” rating in a research report on Thursday, April 13th. Two analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Humana has a consensus rating of “Moderate Buy” and an average target price of $600.56.
Insiders Place Their Bets
Humana Price Performance
NYSE:HUM opened at $444.80 on Thursday. The company has a quick ratio of 1.39, a current ratio of 1.39 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $55.57 billion, a P/E ratio of 18.07, a P/E/G ratio of 1.17 and a beta of 0.72. Humana Inc. has a 52 week low of $435.00 and a 52 week high of $571.30. The stock’s fifty day moving average is $500.79 and its two-hundred day moving average is $500.99.
Humana (NYSE:HUM – Free Report) last posted its quarterly earnings data on Wednesday, April 26th. The insurance provider reported $9.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.25 by $0.13. The firm had revenue of $26.74 billion for the quarter, compared to the consensus estimate of $26.40 billion. Humana had a return on equity of 21.04% and a net margin of 3.26%. The company’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $8.04 EPS. Equities analysts expect that Humana Inc. will post 28.28 EPS for the current year.
Humana Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, July 28th. Shareholders of record on Friday, June 30th will be issued a dividend of $0.885 per share. The ex-dividend date is Thursday, June 29th. This represents a $3.54 annualized dividend and a yield of 0.80%. Humana’s dividend payout ratio (DPR) is 14.38%.
Humana Profile
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Stories
- Five stocks we like better than Humana
- AMD’s Recent Correction: A Buying Opportunity For Investors?
- AeroVironment’s New Momentum Makes it a Value Play
- Unifirst: Undervalued At Rock-Bottom Prices
- Jefferies Misses on Earnings: Does it Signal a Speed Bump or U-Turn?
- General Mills Retreats To The Buy Zone
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
